miércoles, 25 de septiembre de 2024
Drug Trials Snapshots: XACDURO (sulbactam for injection; durlobactam for injection), co-packaged for intravenous use
XACDURO is an antibacterial drug to treat adults who have hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by specific bacteria called Acinetobacter baumannii-calcoaceticus complex. It should not be used to treat pneumonia, which is caused by other bacteria.
https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-xacduro
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario